ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT Q2 2026
Zinzino group revenue increased 17% in Q2, compared with the previous year.
The revenue in June for Zinzino's sales markets increased by 14% and amounted to SEK 296.8 (259.3.9) million. Faun Pharma's external sales increased and amounted to SEK 6.0 (4.9) million. Overall, the Group increased revenues by 15% to SEK 302.8 (264.2) million compared with the previous year.
Revenue in Zinzino's sales markets increased by 17% in the second quarter of 2026 compared with the same period last year and amounted to SEK 914.9 (779.5) million. Total revenues in the Group increased by 17% in the second quarter and amounted to SEK 930.2 (794.5) million.
Accumulated revenue for January – June 2026 increased by 22% to SEK 1,852.9 (1,518.1) million.
Revenues were distributed as follows:
|
Regions, mSEK |
26-jun |
25-jun |
Change |
Q2 2026 |
Q2 2025 |
Change |
YTD 2026 |
YTD 2025 |
Change |
|
The Nordics |
25.1 |
25.6 |
-2% |
76.6 |
78.3 |
-2% |
155.1 |
155.4 |
0% |
|
Central Europe |
90.9 |
81.2 |
12% |
280.7 |
218.7 |
28% |
556.3 |
415.1 |
34% |
|
East Europe |
25.3 |
25.9 |
-2% |
80.9 |
89.3 |
-9% |
166.1 |
186.5 |
-11% |
|
South & West Europe |
49.2 |
45.6 |
8% |
150.0 |
137.1 |
9% |
306.7 |
262.0 |
17% |
|
The Baltics |
8.1 |
8.1 |
0% |
27.0 |
28.0 |
-4% |
56.3 |
56.7 |
-1% |
|
North America |
68.3 |
39.6 |
72% |
207.8 |
137.3 |
51% |
400.1 |
247.5 |
62% |
|
South America |
3.2 |
0.9 |
256% |
10.2 |
2.4 |
326% |
22.6 |
4.7 |
381% |
|
Asia-Pacific |
25.0 |
30.6 |
-18% |
75.9 |
83.2 |
-9% |
142.9 |
149.0 |
-4% |
|
Africa |
1.7 |
1.8 |
-6% |
5.7 |
5.2 |
10% |
12.2 |
10.2 |
20% |
|
Zinzino |
296.8 |
259.3 |
14% |
914.9 |
779.5 |
17% |
1,818.3 |
1,487.1 |
22% |
|
Faun Pharma |
6.0 |
4.9 |
22% |
15.3 |
15.0 |
2% |
34.6 |
31.0 |
12% |
|
Zinzino Group |
302.8 |
264.2 |
15% |
930.2 |
794.5 |
17% |
1,852.9 |
1,518.1 |
22% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-South America: Peru, Colombia
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Tapper Partners AB
Zinzino is a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company’s test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.